Evidence map›Paper›PMID 37363524›Full record

ArticleAnnals of medicine and surgery (2012)2023

Prospects of evolution-based artificial intelligence models in genome-wide studies to stratify genetic risk variants in nonalcoholic fatty liver disease.

Helen Huang, Wireko A Awuah, Tulika Garg, Jyi Cheng Ng, Aashna Mehta, Krishna Ramamoorthy, Jacob Kalmanovich, Mohammad M Hasan

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 7 countries.

Helen HuangRoyal College of Surgeons in Ireland, Faculty of Medicine and Health Science, Dublin, Ireland.ORCID 0000-0002-2809-0154
Wireko A AwuahSumy State University, Sumy, Ukraine.
Tulika GargGovernment Medical College and Hospital, Chandigarh, India.ORCID 0000-0001-7934-0988
Jyi Cheng NgFaculty of Medicine and Health Sciences, University of Putra Malaysia, Serdang, Malaysia.ORCID 0000-0003-3531-5558
Aashna MehtaFaculty of Medicine, University of Debrecen, Debrecen, Hungary.ORCID 0000-0003-2226-0906
Krishna RamamoorthyDepartment of Biochemistry and Microbiology, Rutgers University-New Brunswick, New Jersey.ORCID 0000-0002-5387-2924
Jacob KalmanovichDrexel University College of Medicine, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-4083-4862
Mohammad M HasanDepartment of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
Drexel University · USGovernment Medical College and Hospital · INMawlana Bhashani Science and Technology University · BDRoyal College of Surgeons in Ireland · IERutgers, The State University of New Jersey · USSumy State University · UAUniversiti Putra Malaysia · MYUniversity of Debrecen · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of genome-wide association studies (GWAS) has identified genetic traits and polymorphisms that are associated with the progression of nonalcoholic fatty liver disease (NAFLD). Phospholipase domain-containing 3 and transmembrane 6 superfamily member 2 are genes commonly associated with NAFLD phenotypes. However, there are fewer studies and replicability in lesser-known genes such as LYPLAL1 and glucokinase regulator (GCKR). With the advent of artificial intelligence (AI) in clinical genetics, studies have utilized AI algorithms to identify phenotypes through electronic health records and utilize convolution neural networks to improve the accuracy of variant identification, predict the deleterious effects of variants, and conduct phenotype-to-genotype mapping. Natural language processing (NLP) and machine-learning (ML) algorithms are popular tools in GWAS studies and connect electronic health record phenotypes to genetic diagnoses using a combination of international classification disease (ICD)-based approaches. However, there are still limitations to machine-learning - and NLP-based models, such as the lack of replicability in larger cohorts and underpowered sample sizes, which prevent the accurate prediction of genetic variants that may increase the risk of NAFLD and its progression to advanced-stage liver fibrosis. This may be largely due to the lack of understanding of the clinical consequence in the majority of pathogenic variants. Though the concept of evolution-based AI models and evolutionary algorithms is relatively new, combining current international classification disease -based NLP models with phylogenetic and evolutionary data can improve prediction accuracy and create valuable connections between variants and their pathogenicity in NAFLD. Such developments can improve risk stratification within clinical genetics and research while overcoming limitations in GWAS studies that prevent community-wide interpretations.

Indexed as

artificial intelligencegeneticsmachine-learningnatural language processingnonalcoholic fatty liver disease

Identifiers

PMID37363524
PMCPMC10289529
OpenAlexW4376602497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.